Milestone Pharmaceuticals
MIST
#9234
Rank
HK$1.17 B
Marketcap
HK$9.41
Share price
0.84%
Change (1 day)
-25.08%
Change (1 year)

Revenue for Milestone Pharmaceuticals (MIST)

Revenue in 2026 (TTM): HK$13.89 Million

According to Milestone Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is HK$13.98 Million. In 2025 the company made a revenue of HK$12.02 Million an increase over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Milestone Pharmaceuticals from 2018 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) HK$13.89 M15.51%
2025 HK$12.02 M
2024 N/A-100%
2023 HK$7.81 M-80.01%
2022 HK$39.06 M-66.6%
2021 HK$0.11 B
2020 N/A
2019 N/A
2018 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA